Literature DB >> 11301003

Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction.

Q Lu1, E E Sun, R S Klein, J G Flanagan.   

Abstract

Transmembrane B ephrins and their Eph receptors signal bidirectionally. However, neither the cell biological effects nor signal transduction mechanisms of the reverse signal are well understood. We describe a cytoplasmic protein, PDZ-RGS3, which binds B ephrins through a PDZ domain, and has a regulator of heterotrimeric G protein signaling (RGS) domain. PDZ-RGS3 can mediate signaling from the ephrin-B cytoplasmic tail. SDF-1, a chemokine with a G protein-coupled receptor, or BDNF, act as chemoattractants for cerebellar granule cells, with SDF-1 action being selectively inhibited by soluble EphB receptor. This study reveals a pathway that links reverse signaling to cellular guidance, uncovers a novel mode of control for G proteins, and demonstrates a mechanism for selective regulation of responsiveness to neuronal guidance cues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11301003     DOI: 10.1016/s0092-8674(01)00297-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  106 in total

1.  RGS3 interacts with 14-3-3 via the N-terminal region distinct from the RGS (regulator of G-protein signalling) domain.

Authors:  Jiaxin Niu; Astrid Scheschonka; Kirk M Druey; Amanda Davis; Eleanor Reed; Vladimir Kolenko; Richard Bodnar; Tatyana Voyno-Yasenetskaya; Xiaoping Du; John Kehrl; Nickolai O Dulin
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

Review 2.  CXC chemokine receptors in the central nervous system: Role in cerebellar neuromodulation and development.

Authors:  Davide Ragozzino
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Adaptor protein Crk is required for ephrin-B1-induced membrane ruffling and focal complex assembly of human aortic endothelial cells.

Authors:  Ken-Ichiro Nagashima; Akira Endo; Hisakazu Ogita; Akiko Kawana; Akiko Yamagishi; Akira Kitabatake; Michiyuki Matsuda; Naoki Mochizuki
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

Review 4.  Neuronal migration and molecular conservation with leukocyte chemotaxis.

Authors:  Yi Rao; Kit Wong; Michael Ward; Claudia Jurgensen; Jane Y Wu
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

5.  Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons.

Authors:  Yan Zhu; Tao Yu; Xiao-Chun Zhang; Takashi Nagasawa; Jane Y Wu; Yi Rao
Journal:  Nat Neurosci       Date:  2002-08       Impact factor: 24.884

6.  Interactions between Eph kinases and ephrins provide a mechanism to support platelet aggregation once cell-to-cell contact has occurred.

Authors:  Nicolas Prevost; Donna Woulfe; Takako Tanaka; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

7.  Loss-of-function analysis of EphA receptors in retinotectal mapping.

Authors:  David A Feldheim; Masaru Nakamoto; Miriam Osterfield; Nicholas W Gale; Thomas M DeChiara; Rajat Rohatgi; George D Yancopoulos; John G Flanagan
Journal:  J Neurosci       Date:  2004-03-10       Impact factor: 6.167

Review 8.  Ephrin reverse signaling in axon guidance and synaptogenesis.

Authors:  Nan-Jie Xu; Mark Henkemeyer
Journal:  Semin Cell Dev Biol       Date:  2011-10-24       Impact factor: 7.727

9.  Possible role of Efnb1 protein, a ligand of Eph receptor tyrosine kinases, in modulating blood pressure.

Authors:  Zenghui Wu; Hongyu Luo; Eric Thorin; Johanne Tremblay; Junzheng Peng; Julie L Lavoie; Yujia Wang; Shijie Qi; Tao Wu; Jiangping Wu
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

10.  A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

Authors:  Joshua B Rubin; Andrew L Kung; Robyn S Klein; Jennifer A Chan; YanPing Sun; Karl Schmidt; Mark W Kieran; Andrew D Luster; Rosalind A Segal
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.